Mutagenic activity of cisplatin in thelacZ plasmid-based transgenic mouse model

This publication has 28 references indexed in Scilit:

• Evaluation of a plasmid-based transgenic mouse model for detecting in vivo mutations
  Mutagenesis, 1996
• Mutational specificity: Mutational spectra in transgenic animal research: Data analysis and study design based upon the mutant or mutation frequency
  Environmental and Molecular Mutagenesis, 1996
• Transplacental Carcinogenesis by Cisplatin in F344/NCR Rats: Promotion of Kidney Tumors by Postnatal Administration of Sodium Barbital
  Toxicology and Applied Pharmacology, 1995
• Mutagenicity and genotoxicity of the major DNA adduct of the antitumor drug cis-diamminedichloroplatinum(II)
  Biochemistry, 1993
• Single d(ApG)/cis-diamminedichloroplatinum(II) adduct-induced mutagenesis in Escherichia coli.
  Proceedings of the National Academy of Sciences, 1990
• Sequence specificity of mutation induced by the anti-tumor drug cisplatin in the CHO aprt gene
  Carcinogenesis: Integrative Cancer Research, 1989
• Spectrum of cisplatin-induced mutations in Escherichia coli.
  Proceedings of the National Academy of Sciences, 1987
• Cisplatin as an initiating agent in two-stage mouse skin carcinogenesis
  Cancer Letters, 1985
• Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation
  Biochemistry, 1985
• Base-pair substitution hotspots in GAG and GCG nucleotide sequences in Escherichia coli K-12 induced by cis-diamminedichloroplatinum (II).
  Proceedings of the National Academy of Sciences, 1981